# Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds

> **NCT06885775** · PHASE2 · NOT_YET_RECRUITING · sponsor: **DEXLEVO** · enrollment: 80 (estimated)

## Conditions studied

- Dermal Fillers
- Nasolabial Folds, Wrinkles

## Interventions

- **DEVICE:** DXP01
- **DEVICE:** Juvederm ULTRA 3

## Key facts

- **NCT ID:** NCT06885775
- **Lead sponsor:** DEXLEVO
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-28
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06885775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06885775, "Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06885775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*